about
Gene expression and hepatitis C virus infectionA quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasiaMalignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cellsPerformance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataElafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.Use of laser capture microdissection for clonal analysis.Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases.Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin.Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion.Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study.Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue.Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis CImaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis.Appropriateness of liver biopsy.Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation.Definition and natural history of metabolic steatosis: histology and cellular aspects.Proteomic screening identifies a YAP-driven signaling network linked to tumor cell proliferation in human schwannomasProteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass lossTransforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon.Identification of pro-EPIL and EPIL peptides translated from insulin-like 4 (INSL4) mRNA in human placenta.Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas.Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas.Changes in autophagic response in patients with chronic hepatitis C virus infection.Approaches for treatment of liver fibrosis in chronic hepatitis C.In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms.Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.Liver extracellular matrix in health and disease.Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy.Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease.Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement.Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index.Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domainSerological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses.Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor
P50
Q27488345-A1B28F08-86D0-4EDC-80B5-4539035340F1Q28179840-85A485EC-F5F8-4A48-865B-445C7E99FA71Q28302335-5E27AEB8-597D-4F99-835C-4006BB727366Q28481485-A4C8640F-B6D2-4350-8B02-9FB3A4CCC8F6Q30277347-D20850E7-146E-4334-9E30-982B4AD47C9AQ30868571-3FC6AD7F-D5F3-48BC-A509-6D9BC2C7AC58Q33211462-7C162677-8CB2-4A15-988F-DDB67ADC7D0FQ33246213-E6801384-AA77-4D29-8819-BC5A8F5D3FEEQ33250475-30BDC526-FB61-4AA6-A16B-0355158D10EFQ33539003-F032F76B-E2F4-463E-9170-4F20AE73F014Q33629823-2F0D6A5C-0A46-4D6A-875E-24D9DCB7F4B9Q33887760-F44CD23F-C5CA-478B-BA72-48A52593878FQ33933462-32734400-4D11-4F17-8339-1FBBB3090447Q33963882-DC46FEF6-E0C3-4F92-9BA7-23DD8D8365DFQ33991839-5C739A69-9219-4F13-9E31-28DEF883FB94Q34015966-74F18A4F-1DA8-44B5-A020-A841EDD41EBCQ34062012-82B4BA2C-80E2-45EA-A63B-820F0CACDD45Q34072811-65BF6D4E-8224-48C1-8800-DFFE9C1BECEAQ34237665-298504B8-B20B-48D4-84FC-121D2C8A944EQ34375945-A12F265C-6F51-423C-A939-50C6E736A48DQ34437838-0CB499EF-CD94-41A0-8C52-68DDD624171AQ34647317-777EE18B-1177-4188-A150-E7E2769ECEC9Q34757375-8AB1C95F-83D4-4197-BB18-279A8C06D668Q35010290-52702B51-1281-46D8-86FA-3E7C95A23F81Q35071429-D2E9BFFA-59D7-4B84-89EB-B85089D5A232Q35105721-61633474-E40F-4BF8-9A57-12F0A7FBC263Q35126024-671F1AF1-F18B-4B6A-B99C-694691A2FFD3Q35134122-5D6226D9-1614-46A4-A79B-62BE06506DF7Q35170449-1865EDA8-FACF-41FF-BBCC-6BAC6B38D415Q35198372-8427BCFE-BE9B-4A3E-874C-EB755C7CE8C0Q35597990-4C990AA9-0FA1-42F8-A8CB-0139A0098604Q35656931-BF6AD794-4E0A-413C-82BF-0FF418A14A71Q35761351-7C3204E8-78A6-4BE2-972C-1AE165067FCBQ35791700-924FE2C3-E638-40D1-8815-C8764A8B315DQ35831642-51A9CDF3-8A3D-42A5-8FFF-F0D56CB38AE9Q36052963-3DDA102E-FDF4-4724-BA7D-AEA453861950Q36156172-E4DAEB50-2729-49FF-9498-8BD658A97DC4Q36236746-9C91AC58-E5CE-4278-B735-ABC35346FE85Q36298938-C590EFF3-A6E2-4B42-AABE-DFF02EB5943AQ36650363-3933395E-964A-4AB0-A4C8-1A39C6FB3BE2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pierre Bedossa
@ast
Pierre Bedossa
@en
Pierre Bedossa
@es
Pierre Bedossa
@nl
Pierre Bedossa
@sl
type
label
Pierre Bedossa
@ast
Pierre Bedossa
@en
Pierre Bedossa
@es
Pierre Bedossa
@nl
Pierre Bedossa
@sl
prefLabel
Pierre Bedossa
@ast
Pierre Bedossa
@en
Pierre Bedossa
@es
Pierre Bedossa
@nl
Pierre Bedossa
@sl
P106
P21
P31
P496
0000-0002-8487-7322